Company profile
Mediar Therapeutics
Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression.
- Industry
- Biotechnology Research
- Employees
- 56
- Headquarters
- Boston, Massachusetts
- Founded
- 2019
- LinkedIn followers
- 5,341
- Office locations
- 1
Mediar Therapeutics company summary
Mediar Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2019. On LinkedIn the company has around 56 employees and 5,341 followers.
What technology does Mediar Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Mediar Therapeutics
Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact info@mediartx.com
Where is Mediar Therapeutics located?
Mediar Therapeutics lists 1 location.
Compare companies similar to Mediar Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Mediar Therapeutics mediartx.com | Biotechnology Research | 56 | 2019 | Boston, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Mediar Therapeutics
What does Mediar Therapeutics do?
Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact info@mediartx.com
How many employees does Mediar Therapeutics have?
Mediar Therapeutics has around 56 employees on LinkedIn.
Where is Mediar Therapeutics headquartered?
Mediar Therapeutics is headquartered in Boston, Massachusetts.
When was Mediar Therapeutics founded?
Mediar Therapeutics was founded in 2019.
Build a lead list from companies like Mediar Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.